Abstract:Objective To investigate the clinical risk factors related to the cirrhosis development in patients with hepatitis B virus infection. Methods A total of 988 participants with hepatitis B virus infection were collected for this study in Zhong Shan Hospital affiliated with Fu Dan University between January 2009 and January 2011. All of them were Chinese Han nationality from Shanghai and its surrounding area. Their information, including hepatitis history, serum test, liver imaging, and liver histology if available, were collected. They were divided into healthy recovered and chronic hepatitis group, the later was subdivided into cirrhotic group and non-cirrhotic group. The general informations and clinical determination datas were compared with statistical analysis by using SPSS 18.0 and STATA 11.0 software. Results (1) The ratio of male/female participants was 736/252, and the average age was 50.8±13.2. The numbers of participants in healthy recovered group, non-cirrhotic chronic hepatitis and cirrhotic group were 274, 285, and 429, respectively, and the average ages were 56.7±13.6, 49.2±11.5, and 47.5±13.5, respectively. Chronic hopatitis B (CHB) familial history was found in 2.2% participants of the healthy recovered group and 47.5% participants of chronic hepatitis group. The vertical infection rates were 56.3% in healthy recovered group, and 93.7% in chronic hepatitis group, which have significant difference between them. For chronic hepatitis group, the vertical rates of non-cirrhotic and cirrhotic group were 89.4% and 96.4%, respectively, which also have significant difference between them. The vertical infection was a risk factor for chronicity of hepatitis B (OR=15.02, 95% CI:9.57-23.94) and the development of cirrhosis (OR=3.15, 95%CI:1.39-7.45). The duration of disease of cirrhotic patients (44.1±9.5 years) was longer than that of non-cirrhotic CHB patients (39.3±9.8 years). The ratio of male patients in cirrhotic group was also significantly higher than that in non-cirrhotic group (70.2%) and the duration of disease for male patients (41.7±9.3 years) were shorter than that of female patients (45.0±11.4 years).(2) The levels of liver function rests were significantly different among healthy recover, non-cirrhotic, and cirrhotic group of CHB patients. There were negative correlation between HBsAg and HBV DNA in HBeAg positive patients (r=-0.43);However positive correlation in HBeAg negative patients (r=0.23) was observed. HBsAg level, which was higher than 1 000 COI, of cirrhotic patients (89.5%) was significant higher than that of non-cirrhotic patients (89.5%) (OR=1.86, 95% CI:1.18-2.94). No correlation was found betweem HBV DNA level and the duration of disease of CHB (P=0.21). Although HBV DNA level in cirrhotic group was significantly higher than that in non-cirrhotic group (2.875±2.68 log10copies/mL), the ratio of patients with HBV DNA level, which was higher than 5 log10copies/mL in cirrhotic group (31%) was significantly lower than that in non-cirrhotic group(57.2%). Conclusion The factors associated with cirrhosis development in CHB patients include duration of diseases, familial history, route of infection (vertical infection), male gender, the level of HBsAg(higher than 1 000 COI), and HBV DNA level.

Changing trends of hospitalisation of liver cirrhosis in Beijing, China.

Changing spectrum and mortality disparities of etiology of liver cirrhosis in Beijing, China

Study of liver cirrhosis over twenty consecutive years in adults in Southern China

Etiological Features of Cirrhosis Inpatients in Beijing, China.

Mortality trends of liver diseases in mainland China over three decades: an age-period-cohort analysis

Changing trends in viral hepatitis mortality in East and Southeast Asia between 1987 and 2015 and its prediction until 2030

Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.

Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol

The Burden of Liver Cirrhosis and Underlying Etiologies: Results from the Global Burden of Disease Study 2019

[Investigate of the etiology and prevention status of liver cirrhosis]

Trends in Mortality of Cirrhosis in China: An Analysis of the China Death Surveillance Database from 2008 to 2020

Trends in the burden of hospitalised patients with cirrhosis in Switzerland: a cross-sectional study of cirrhosis-related hospitalisations between 1998 and 2020

Evaluation of the clinical risk factors associated with liver cirrhosis in patients with chronic hepatitis B viral infection

Trends in Mortality of Liver Disease Due to Hepatitis B in China from 1990 to 2019: Findings from the Global Burden of Disease Study.

Changing global epidemiology of chronic hepatitis C virus-related outcomes from 2010 to 2019: cirrhosis is the growing burden of hepatitis C virus-related disease

The burden of liver cirrhosis in mortality: Results from the global burden of disease study

Long-term trends in incidence, mortality and burden of liver cancer due to specific etiologies in Hubei Province

Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004–2021: a population-based surveillance study

[Changes of hospitalization rates and in-hospital mortality for coronary heart disease in Beijing from 2007-2012].

[Study on Changes in Hepatitis B Incidence in China, 1990-2017].

The Epidemiology of Hepatitis B and Hepatitis C Infections in China from 2004 to 2014: an Observational Population‐based Study